Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Schott

Showing results (41-50 of 376) with videos related to

Pageof 38
Sort By:
Neuroimage|February 8, 2011
Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trialsNick C Fox, Gerard R Ridgway, Jonathan M Schott
Archives of Neurology|December 17, 2003
The uncertain nosology of Hashimoto encephalopathyJonathan M Schott, Jason D Warren, Martin N Rossor
Annals of Neurology|September 30, 2004
Dementia in dementia with Lewy bodies may not be attributable to Alzheimer pathologyJonathan M Schott, Andrew J Lees, Martin N Rossor
Molecular Diagnosis & Therapy|October 15, 2016
Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious ProgressAshvini Keshavan, Amanda Heslegrave, Henrik Zetterberg, et al.
Expert Review of Neurotherapeutics|June 13, 2017
The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trialsBob Olsson, Jonathan M Schott, Kaj Blennow, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 14, 2018
Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cyclesAshvini Keshavan, Amanda Heslegrave, Henrik Zetterberg, et al.
The Lancet. Neurology|July 18, 2023
Preparing for disease-modifying therapies in Alzheimer's diseaseChristopher R S Belder, Jonathan M Schott, Nick C Fox
EMBO Molecular Medicine|August 2, 2021
Aducanumab: a new phase in therapeutic development for Alzheimer's disease?Giovanna Lalli, Jonathan M Schott, John Hardy, et al.
Nature Reviews. Neurology|September 17, 2024
Preparing for disease-modifying dementia therapies in the UKClaudia Cooper, Charles R Marshall, Jonathan M Schott, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 16, 2015
Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scalesLorna Harper, Frederik Barkhof, Nick C Fox, et al.
Pageof 38

Showing results (41-50 of 376) with videos related to

Sort By:
Pageof 38
Neuroimage|February 8, 2011
Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trialsNick C Fox, Gerard R Ridgway, Jonathan M Schott
Archives of Neurology|December 17, 2003
The uncertain nosology of Hashimoto encephalopathyJonathan M Schott, Jason D Warren, Martin N Rossor
Annals of Neurology|September 30, 2004
Dementia in dementia with Lewy bodies may not be attributable to Alzheimer pathologyJonathan M Schott, Andrew J Lees, Martin N Rossor
Molecular Diagnosis & Therapy|October 15, 2016
Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious ProgressAshvini Keshavan, Amanda Heslegrave, Henrik Zetterberg, et al.
Expert Review of Neurotherapeutics|June 13, 2017
The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trialsBob Olsson, Jonathan M Schott, Kaj Blennow, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 14, 2018
Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cyclesAshvini Keshavan, Amanda Heslegrave, Henrik Zetterberg, et al.
The Lancet. Neurology|July 18, 2023
Preparing for disease-modifying therapies in Alzheimer's diseaseChristopher R S Belder, Jonathan M Schott, Nick C Fox
EMBO Molecular Medicine|August 2, 2021
Aducanumab: a new phase in therapeutic development for Alzheimer's disease?Giovanna Lalli, Jonathan M Schott, John Hardy, et al.
Nature Reviews. Neurology|September 17, 2024
Preparing for disease-modifying dementia therapies in the UKClaudia Cooper, Charles R Marshall, Jonathan M Schott, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 16, 2015
Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scalesLorna Harper, Frederik Barkhof, Nick C Fox, et al.
Pageof 38